Pharmena S.A. (PHR.WA)

PLN 4.39

(-0.23%)

Eps Summary of Pharmena S.A.

Pharmena S.A.'s latest annual eps in 2023 was 2.60 PLN , up 1833.33% from previous year.
Pharmena S.A.'s latest quarterly eps in 2024 Q2 was -0.08 PLN , down -484.83% from previous quarter.
Pharmena S.A. reported an annual eps of -0.15 PLN in 2022, up 64.29% from previous year.
Pharmena S.A. reported an annual eps of -0.42 PLN in 2021, up 33.33% from previous year.
Pharmena S.A. reported a quarterly eps of -0.08 PLN for 2024 Q2, down -484.83% from previous quarter.
Pharmena S.A. reported a quarterly eps of -0.01 PLN for 2023 Q1, up 82.52% from previous quarter.

Annual Eps Chart of Pharmena S.A. (2023 - 2008)

Historical Annual Eps of Pharmena S.A. (2023 - 2008)

Year	Eps	Eps Growth
2023	2.60 PLN	1833.33%
2022	-0.15 PLN	64.29%
2021	-0.42 PLN	33.33%
2020	-0.63 PLN	33.68%
2019	-0.95 PLN	-1781.19%
2018	-0.05 PLN	81.3%
2017	-0.27 PLN	-42.11%
2016	-0.19 PLN	53.66%
2015	-0.41 PLN	10.87%
2014	-0.46 PLN	-43.75%
2013	-0.32 PLN	44.83%
2012	-0.58 PLN	-41.46%
2011	-0.41 PLN	-2416.38%
2010	0.02 PLN	-83.91%
2009	0.11 PLN	26.44%
2008	0.09 PLN	0.0%

Year	Eps	Eps Growth
2024 Q1	0.02 PLN	149.65%
2024 Q2	-0.08 PLN	-484.83%
2023 Q1	-0.01 PLN	82.52%
2023 Q3	2.71 PLN	5392.97%
2023 Q2	-0.05 PLN	-287.88%
2023 Q4	-0.04 PLN	-101.57%
2023 FY	- PLN	1833.33%
2022 Q3	-0.01 PLN	74.65%
2022 Q2	-0.04 PLN	-161.35%
2022 Q4	-0.08 PLN	-599.07%
2022 FY	- PLN	64.29%
2022 Q1	-0.02 PLN	88.36%
2021 Q2	-0.17 PLN	-230.1%
2021 FY	- PLN	33.33%
2021 Q4	-0.14 PLN	-162.17%
2021 Q3	-0.05 PLN	68.59%
2021 Q1	-0.05 PLN	83.39%
2020 Q1	-0.07 PLN	66.67%
2020 Q2	-0.15 PLN	-114.29%
2020 Q4	-0.31 PLN	-342.86%
2020 FY	- PLN	33.68%
2020 Q3	-0.07 PLN	53.33%
2019 Q2	-0.59 PLN	-949.82%
2019 Q4	-0.21 PLN	-110.0%
2019 FY	- PLN	-1781.19%
2019 Q1	-0.06 PLN	48.91%
2019 Q3	-0.10 PLN	83.05%
2018 Q3	-0.00 PLN	98.04%
2018 Q4	-0.11 PLN	-36566.67%
2018 FY	- PLN	81.3%
2018 Q2	-0.02 PLN	-119.13%
2018 Q1	0.08 PLN	244.14%
2017 FY	- PLN	-42.11%
2017 Q2	-0.11 PLN	-55.59%
2017 Q1	-0.07 PLN	-484.3%
2017 Q3	-0.04 PLN	66.64%
2017 Q4	-0.06 PLN	-51.23%
2016 Q3	0.00 PLN	114.06%
2016 FY	- PLN	53.66%
2016 Q4	-0.01 PLN	-436.11%
2016 Q2	-0.03 PLN	84.0%
2016 Q1	-0.16 PLN	33.33%
2015 Q1	-0.08 PLN	44.14%
2015 Q3	-0.01 PLN	87.85%
2015 Q4	-0.24 PLN	-2300.0%
2015 FY	- PLN	10.87%
2015 Q2	-0.08 PLN	-5.24%
2014 Q4	-0.14 PLN	-376.19%
2014 Q2	-0.12 PLN	33.33%
2014 Q1	-0.18 PLN	-38.46%
2014 FY	- PLN	-43.75%
2014 Q3	-0.03 PLN	75.5%
2013 Q2	-0.09 PLN	-36.04%
2013 Q4	-0.13 PLN	-177.78%
2013 FY	- PLN	44.83%
2013 Q1	-0.07 PLN	66.15%
2013 Q3	-0.05 PLN	49.19%
2012 FY	- PLN	-41.46%
2012 Q3	-0.15 PLN	0.0%
2012 Q4	-0.20 PLN	-33.33%
2011 FY	- PLN	-2416.38%
2010 FY	- PLN	-83.91%
2009 FY	- PLN	26.44%
2008 FY	- PLN	0.0%

Peer Eps Comparison of Pharmena S.A.

Name	Eps	Eps Difference
Bioceltix S.A.	-3.49 PLN	174.499%
BIOTON S.A.	0.03 PLN	-9711.321%
Captor Therapeutics Spolka Akcyjna	-15.19 PLN	117.117%
Mabion S.A.	2.55 PLN	-1.961%
Molecure S.A.	-1.09 PLN	338.532%
NanoGroup S.A.	-0.39 PLN	766.667%
Poltreg S.A.	-2.91 PLN	189.347%
Pure Biologics Spólka Akcyjna	-11.19 PLN	123.235%
Ryvu Therapeutics S.A.	-4.02 PLN	164.677%
Synthaverse S.A.	0.07 PLN	-3740.473%
Urteste S.A.	-4.32 PLN	160.185%